146 related articles for article (PubMed ID: 26246786)
1. Heading off depressive illness evolution and progression to treatment resistance.
Post RM
Dialogues Clin Neurosci; 2015 Jun; 17(2):105-9. PubMed ID: 26246786
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic basis of sensitization to stress, affective episodes, and stimulants: implications for illness progression and prevention.
Post RM
Bipolar Disord; 2016 Jun; 18(4):315-24. PubMed ID: 27346321
[TBL] [Abstract][Full Text] [Related]
3. The Kindling/Sensitization Model and Early Life Stress.
Post RM
Curr Top Behav Neurosci; 2021; 48():255-275. PubMed ID: 33432554
[TBL] [Abstract][Full Text] [Related]
4. How to prevent the malignant progression of bipolar disorder.
Post RM
Braz J Psychiatry; 2020; 42(5):552-557. PubMed ID: 32578689
[TBL] [Abstract][Full Text] [Related]
5. Management of treatment-resistant depression.
Keitner GI; Mansfield AK
Psychiatr Clin North Am; 2012 Mar; 35(1):249-65. PubMed ID: 22370501
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of illness progression in the recurrent affective disorders.
Post RM
Neurotox Res; 2010 Nov; 18(3-4):256-71. PubMed ID: 20390474
[TBL] [Abstract][Full Text] [Related]
7. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena.
Post RM
Neurosci Biobehav Rev; 2007; 31(6):858-73. PubMed ID: 17555817
[TBL] [Abstract][Full Text] [Related]
8. Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression.
Post RM; Weiss SR
Biol Psychiatry; 1998 Aug; 44(3):193-206. PubMed ID: 9693391
[TBL] [Abstract][Full Text] [Related]
9. Neurobiological correlates of illness progression in the recurrent affective disorders.
Post RM; Fleming J; Kapczinski F
J Psychiatr Res; 2012 May; 46(5):561-73. PubMed ID: 22444599
[TBL] [Abstract][Full Text] [Related]
10. [Staging of unipolar affective illness].
Ferensztajn E; Remlinger-Molenda A; Rybakowski J
Psychiatr Pol; 2014; 48(6):1127-41. PubMed ID: 25717483
[TBL] [Abstract][Full Text] [Related]
11. Relation of stressors and depressive symptoms to clinical progression of viral illness.
Zorrilla EP; McKay JR; Luborsky L; Schmidt K
Am J Psychiatry; 1996 May; 153(5):626-35. PubMed ID: 8615407
[TBL] [Abstract][Full Text] [Related]
12. Sensitization, kindling, and anticonvulsants in mania.
Post RM; Weiss SR
J Clin Psychiatry; 1989 Dec; 50 Suppl():23-30; discussion 45-7. PubMed ID: 2689434
[TBL] [Abstract][Full Text] [Related]
13. [Influence of depressive history on biological parameters in major depression].
Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
[TBL] [Abstract][Full Text] [Related]
14. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder.
Post RM
Am J Psychiatry; 1992 Aug; 149(8):999-1010. PubMed ID: 1353322
[TBL] [Abstract][Full Text] [Related]
15. Stress and depression.
Hammen C
Annu Rev Clin Psychol; 2005; 1():293-319. PubMed ID: 17716090
[TBL] [Abstract][Full Text] [Related]
16. Identifying patients with depression who require a change in treatment and implementing that change.
Papakostas GI
J Clin Psychiatry; 2016 Feb; 77 Suppl 1():16-21. PubMed ID: 26829433
[TBL] [Abstract][Full Text] [Related]
17. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.
Moylan S; Maes M; Wray NR; Berk M
Mol Psychiatry; 2013 May; 18(5):595-606. PubMed ID: 22525486
[TBL] [Abstract][Full Text] [Related]
18. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
19. Assessing the risk factors for difficult-to-treat depression and treatment-resistant depression.
Gaynes B
J Clin Psychiatry; 2016 Feb; 77 Suppl 1():4-8. PubMed ID: 26829431
[TBL] [Abstract][Full Text] [Related]
20. Sensitization components of post-traumatic stress disorder: implications for therapeutics.
Post RM; Weiss SR; Li H; Leverich GS; Pert A
Semin Clin Neuropsychiatry; 1999 Oct; 4(4):282-94. PubMed ID: 10553034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
